当前位置:

网站首页>文章详情

超大剂量厄贝沙坦治疗扩张型心肌病1例

【PDF在线阅读】 【下载PDF】
  • Author:

  • 作者单位:

  • Author Unit:

  • 关键词:

  • Keywords:

摘要:

Abstract:

基金项目:

参考文献:

[1] Weintraub RG,Semsarian C,Macdonald P. Dilated cardiomyopathy[J]. The Lancet,2017,(16)31713-5.
[2] Park J,Kim J,Seo K,et al. Recurrence of Left Ventricular Dysfunction in Patients With Restored Idiopathic Dilated Cardiomyopathy[J]. Clin Cardiol,2014,37(4):222-6.
[3] Ponikowski P,Voors AA,Anker SD,et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure[J]. Eur Heart J,2016,37(27):2129-200.
[4] Yancy CW,Jessup M,Bozkurt B,et al. 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure:An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure[J]. J Card Fail,2016,22(9):659-69.
[5] 张健,邹长虹. 扩张型心肌病患者左心室逆重构[J]. 中华心血管病杂志,2016,44(4):287-91.
[6] He Z,Sun Y,Gao H,et al. Efficacy and safety of supramaximal titrated inhibition of renin-angiotensin-aldosterone system in idiopathic dilated cardiomyopathy[J]. ESC HEART FAILURE,2015(2):129-38.
[7] Ruzicka M,Floras JS,Mcreynolds AJG,et al. Do high doses of AT1- receptor blockers attenuate central sympathetic outflow in humans with chronic heart failure?[J]. Clin Sci,2013,124(9):589-95.
[8] Brunner-La RH,Weilenmann D,Kiowski W,et al. Within-patient comparison of effects of different dosages of enalapril on functional capacity and neurohormone levels in patients with chronic heart
failure[J].Am Heart J,1999,138(4 Pt 1):654-62.
[9] Packer M,Poole-Wilson PA,Armstrong PW,et al. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group[J]. Circulation,1999,100(23):2312-8.
[10] Nanas JN,Alexopoulos G,Anastasiou-Nana MI,et al. Outcome of patients with congestive heart failure treated with standard versus high doses of enalapril: a multicenter study. High Enalapril Dose Study Group[J]. J Am Coll Cardiol,2000,36(7):2090-5.
[11] Ishida J,Konishi M,von Haehling S. The appropriate dose of angiotensin-converting- enzyme inhibitors or angiotensin receptor blockers in patients with dilated cardiomyopathy. The higher,the
better[J]. ESC HEART FAILURE,2015(2):103-5.
[12] Weinberg AJ,Zappe DH,Ashton M,et al. Safety and tolerability of highdose angiotensin receptor blocker therapy in patients with chronic kidney disease:a pilot study[J]. Am J Nephrol,2004,24(3):340-5.
[13] Burgess E,Muirhead N,de Cotret PR,et al. Supramaximal Dose of Candesartan in Proteinuric Renal Disease[J]. J Am Soc Nephrol,2009,20(4):893-900.
[14] Hollenberg NK,Parving H,Viberti G,et al. Albuminuria response to very high-dose valsartan in type 2 diabetes mellitus[J]. J Hypertens, 2007,25(9):1921-6.
[15] Drakos SG,Papamichael CM,Alexopoulos GP,et al. Effects of High Doses Versus Standard Doses of Enalapril on Endothelial Cell Function in Patients With Chronic Congestive Heart Failure
Secondary to Idiopathic Dilated or Ischemic Cardiomyopathy[J]. Am J Cardiol,2003,91(7):885-8.
[16] Guo L Y,Liu B,Sun Z C,et al. Miraculous Recovery of a Dilated Heart after Usage of Supramaximal Titrated Valsartan for 8 Months[J]. Chinese Med J-Peking,2016,129(22):2771-2.
[17] 张亮,贺媛,袁铭. 长期大剂量ACEI治疗改善扩张型心肌病患者心功能1例[J]. 心脏杂志,2017(3):376-7.
  • 2008

  • 1

通讯地址:北京市东城区东四十条南门仓5号
电话: 237499284 邮编:100700
网址:www.ebcvm..org Email: ebcvm_cj@126.com

copyright © 《中国循证心血管医学杂志》编辑部
当您在使用本网站投稿遇到困难时,
请直接将稿件投送到编辑部邮箱ebcvm_cj@126.com